Hoth Therapeutics has entered into a service agreement with Shareholder Intelligence Services, a patented compliance driven SAAS retained by public companies to track shareholder ownership and monitor critical broker-dealer and shareholder movement, to investigate and report on potential illegal naked short selling activities of company stock, among other potential trading violations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on HOTH:
- Hoth Therapeutics reports results of is AD’s therapeutic HT-ALZ
- Hoth selects its clinical sites for clinical trial of treatment for EGFR
- Biotech Alert: Searches spiking for these stocks today
- After Massive Rally, HOTH Tanks on Private Placement
- Hoth Therapeutics price target lowered to $33 from $45 at EF Hutton